Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
CA 2466927 A1 · Owner: Roby, Russell R. · Inventors: Roby, Russell R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method and composition for the treatment of hormone allergy is disclosed. The method relates to using progesterone dilutions or any other steroid , hormone, to treat the systemic symptoms of hormone allergy including pain. , The composition of the hormone dilutions ranges from 10-1 to 10-5. The hormone dilution may be administered sublingually or, in the alternative, an , intradermal route of administration may be chosen. Hormone dilutions may be administered at daily intervals or on any other treatment schedule as required to alleviate a patient's symptoms.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 18, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 18, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 18, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.